Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

June 01,2024

The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them.

Landmark Study Shows Comprehensive Heart Benefits of Wegovy Beyond Weight Loss

Wegovy cuts risk of cardiovascular events by 20%, study finds

Wegovy Getting More Popular, Could Reduce Risk of Heart Attack and Stroke - North Carolina Medical Society

Obesity drug Wegovy cut risk of serious heart problems by 20%: Study

Study Finds Wegovy Drug Reduces Heart Attack, Stroke Risks by 20%

Weight-Loss Drug Wegovy Cuts Stroke, Heart-Attack Risk by 20% in New Study - WSJ

Obesity drug Wegovy reduces serious heart disease risk by 20%: Study

Weight loss drug significantly reduces the risk of heart attacks and strokes, study finds

Wegovy cuts heart attack risk, so will health insurers now cover weight loss drugs?

New Study Finds Semaglutide May Reduce Heart Attack Risk - Parade

Weight-loss drug cut risk of heart attack, stroke by 20% in large trial

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds –